A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

Ki vehet részt

• Part I:
• Adult greater than or equal to (>=)18 years of age or Canadian adult >=19 years of age
• Ability to consent, as judged by the study investigator
• Diagnosis of at least one psychiatric disorder of at least 12 months duration, based on International classification of diseases (ICD)-10 codes registered in electronic health records
• Consecutive assessment for ADHD (as per routine clinical practice)
• Able to read and write in the first language of the respective country; Part II
• Inclusion in study Part I
• Diagnosis of ADHD during Part I, according to routine diagnostic procedure and algorithms
• Anticipated availability for being followed over 9 months

Ki nem vehet részt

• Diagnosis of any of the following at any time prior to signing informed consent: schizoaffective disorder, intellectual disability, or other cognitive disorders
• Occurrence of any of the following events within the 6 months prior to signing consent: psychotic episodes, acute intoxication, or psychotropic drug withdrawal syndrome
• Participation in a clinical interventional trial in the 12 months prior signing consent; Part II:
• Serious and unstable medical condition (severe disease that limits survival to 1 year)
• Part I:
• Diagnosis of ADHD at any time before study inclusion
• Participant being followed-up for ADHD in a different site